Health-care costs are rising, driven by expensive developments in treatments, more demanding populations and rising national wealth. We need to change the financing system to meet this challenge.
Academic rigor, journalistic flair
Articles on Health economics
Displaying 141 - 160 of 254 articles
Waiting for emergency care, specialist appointments and “elective” procedures is not only inconvenient and frustrating, it can also be painful and detrimental to your health and well-being.
Why is it so difficult to find out exactly how much it’s going to cost to have that suspicious mole removed or to be admitted to hospital for that colonoscopy or hip replacement?
In a time of growing populations, hospitals must guarantee access, ensure quality, minimise the chances of anything going wrong, and do it all within the available budget. So they need to change.
What are the most common reasons for going to hospital? What can go wrong? What’s behind the state-Commonwealth funding fight? Our at-a-glance infographic has the answers.
The 5.6% increase amounts to the average family paying about $300 more a year for an average policy.
We start 2016 with big challenges for the health system and uncertainty as to how governments will meet them.
This was the year of the health review – mental health care, Medicare, private health insurance, the pharmacy industry … and the list goes on. But how much movement was there on policy?
The Coalition tried to justify its failed GP co-payment as an attempt to rein in consumers, who were driving the increase in Medicare costs. Turns out government policy was mostly to blame.
Chronic diseases are responsible for nine out of ten deaths in Australia, and for much of the public health expenditure that’s causing governments so much concern.
All insurers would have to provide a comprehensive set of health services to its customer, covering all aspects of their health care.
Australians are picking up some of the slack of government belt-tightening by paying more for health, with experts concerned this could reduce the equity in Australia’s health system.
It looks like where you live, and what regulations that state has for health insurers, may have a major impact on whether you are diagnosed early or not.
Most of us would agree that cancer drugs should be listed on the PBS, no matter how dear. But our health system can’t afford all of them. How then are decisions about which drugs to subsidise made?
Economic modelling shows that policies to reduce chronic diseases can have large economic benefits –A$4.5 billion a year for diabetes alone – by reducing health costs and boosting the workforce.
To avoid ineffective treatments, we need a new way to identify and reduce questionable care. A new Grattan Institute report shows how to do it.
State and territory leaders will meet in Sydney today to nut out solutions to health and education funding gaps. But what exactly is the problem they’re hoping to address?
Any health reform proposals should start by addressing public hospitals and chronic care. But successful change in these areas requires getting the state-Commonwealth funding and incentives right.
Data analysed from 32 countries shows women make a huge economic contribution that often goes unrecognised (and unpaid).
The big surprise about this year’s health budget was what wasn’t there – billions of dollars in expected savings from the Pharmaceutical Benefits Scheme.
Top contributors
-
Honorary Enterprise Professor, School of Population and Global Health, and Department of General Practice and Primary Care, The University of Melbourne
-
Program Director, Health and Aged Care, Grattan Institute
-
Professor of Health Economics and Director, Centre for Health Economics, Monash Business School, Monash University
-
Professor of Health Economics, The University of Melbourne
-
Adjunct Associate Professor, Menzies Centre for Health Policy and Economics, University of Sydney
-
Reader in Health Economics, Centre for Health Economics, University of York
-
Professor of Health Economics and Director, Centre for Health Economics Research and Evaluation, University of Technology Sydney
-
Health economist, University of Sydney
-
Professor and Director, Macquarie University Centre for the Health Economy, Macquarie University
-
Professor, Public Service Research, UNSW Sydney
-
Professor of Health Economics, Flinders University
-
Jim Gillespie is a Friend of The Conversation.
Associate Professor in Health Policy, Menzies Centre for Health Policy & Sydney School of Public Health, University of Sydney
-
Senior Policy Adviser, National Rural Health Alliance; Adjunct Lecturer, University of Sydney
-
Lecturer, Public Sector Finance, University of Canberra
-
Emeritus Professor, Menzies Centre for Health Policy, University of Sydney
